#Regenerative Medicine

The 2025 Revisions to the Pharmaceuticals and Medical Devices Act ― Impact on the Life Sciences and Healthcare Industry and Remaining Challenges ―

Pharmaceutical and Healthcare Seminar

• Kensuke Suzuki
• Masanori Tosu
• Tomoharu Hagiwara

Nagashima Ohno & Tsunematsu Tokyo Office

• Pharmaceutical and Healthcare
• Medical, Pharmaceutical and Life Sciences

Japan’s Healthcare Startup Acceleration Measures and Capital Markets

Pharmaceutical and Healthcare Seminar

• Yuichi Miyashita
• Kensuke Suzuki

Online (On-Demand)

• M&A
• Private Equity/Venture Capital and Startups

The Forefront of Life Sciences Legal Practice in an Era of Change – Part 1: Compliance and Risk Management Part 2: M&A and Strategic Partnerships

ADVANCE Corporate Law Seminar

• Kensuke Suzuki
• Ryohei Tanaka
• Kenji Horiuchi

Nagashima Ohno & Tsunematsu Tokyo Office

• Pharmaceutical and Healthcare
• Medical, Pharmaceutical and Life Sciences

Japan’s Healthcare Startup Acceleration Measures and Capital Markets

• Kensuke Suzuki
• Masanori Tosu

Online (On-Demand)

• M&A
• Mergers & Acquisitions
• Private Equity/Venture Capital and Startups

Recent Developments concerning Japan’s Healthcare Startup Acceleration Measures

The NO&T Podcast - JP

• Kensuke Suzuki
• Masanori Tosu

• M&A
• Mergers & Acquisitions
• Private Equity/Venture Capital and Startups

Investment Practices for Life Sciences Startups

Pharmaceutical and Healthcare Seminar

• Kensuke Suzuki
• Kohei Mano

Nagashima Ohno& Tsunematsu (Tokyo)

• M&A
• Private Equity/Venture Capital and Startups